| Control, n = 306 | Intervention, n = 311 | p value |
---|---|---|---|
PIVC failure | 91 (30) | 69 (22) | 0.03 |
Device-time (accumulative days) | 828 | 785 | 0.25 |
Incidence rate per 1000 device days | 110 (89.4–135) | 87·9 (69.4–111) |  |
Incidence rate ratio | Referent | 0.80 (0.58–1.11) | 0.19 |
Secondary outcomes: | |||
 Occlusion | 17 (6) | 18 (6) | 0.90 |
 Leakage | 17 (6) | 7 (2) | 0.03 |
 Infiltration | 40 (13) | 32 (10) | 0.28 |
 Dislodgement | 22 (7) | 19 (6) | 0.59 |
 Phlebitis (research definition) | 20 (9) | 11 (5) | 0.11 |
 Death | 3 (1) | 1 (0) | 0.30 |
 Positive blood culture | 4 (1) | 4 (1) | 0.98 |
Cox regression analysis | Â | Â | Â |
Covariate | Univariable Cox regressiona n = 617 | Multivariable Cox regressionb n = 617 |  |
Study group: intervention | 0.81 (0.59–1.11)* | 0.78 (0.63–0.97)†|  |
Ward sequence (increase by one) | 1.01 (0.88–1.14) | $ |  |
Infection at baseline | 1.68 (1.06–2.66)†| 1.68 (1.10–2.58)†|  |
Extension tubing | 0.72 (0.52–1.00)* | 0.71 (0.57–0.87)†|  |